Compare Axogen Inc (AXGN) vs Meta Platforms Inc (META) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Axogen Inc vs Meta Platforms Inc — how do they compare? Axogen Inc trades at $38.87 (market cap $2.06B), while Meta Platforms Inc trades at $676.87 (market cap $1.68T). The key difference: Meta Platforms Inc is far larger — about 815.5× Axogen Inc's market cap, and Meta Platforms Inc pays a 0.32% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.
| AXGN | META | |
|---|---|---|
Market Cap | $2.06B | $1.68T |
Sector | Technology | Media |
52-Week High | $46.19 | $790.00 |
52-Week Low | $11.28 | $525.72 |
Enterprise Value | $1.98B | $1.68T |
Volume | — | 24,093,972 |
Dividend Yield | — | 0.32% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.
The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.
META stock trades at $674.78, up 2.75% today, reflecting strong momentum near its recent highs. The company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $10.44 significantly exceeding expectations. Revenue growth remains solid, reaching $201.0B in 2025, while profitability metrics like a 32.84% net income margin and 32.93% ROE highlight operational efficiency. Technical indicators show a bullish trend with support at $655 and resistance at $678, though RSI levels suggest potential overbought conditions.
The outlook for META is positive, driven by AI innovations like Muse Spark and strong analyst consensus with a $815.44 price target. However, risks include ongoing litigation, such as the Massachusetts youth addiction lawsuit, and high capital expenditures in AI infrastructure. Investors should weigh the company's growth trajectory against regulatory and execution risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Axogen Inc
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →About Meta Platforms Inc
Meta Platforms Inc., doing business as Meta and previously known as Facebook Inc. It's a company that acts as a parent platform for Facebook, Messenger, Instagram, Whatsapp, Oculus and other subsidiaries. Among these platforms, Facebook is the number one social media platform in terms of the number of active users.
Read more on META →
